Deep Learning Image Analysis of Optical Coherence Tomography Angiography Measured Vessel Density Improves Classification of Healthy and Glaucoma Eyes.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
04 2022
Historique:
received: 06 04 2021
revised: 07 11 2021
accepted: 08 11 2021
pubmed: 16 11 2021
medline: 12 4 2022
entrez: 15 11 2021
Statut: ppublish

Résumé

To compare convolutional neural network (CNN) analysis of en face vessel density images to gradient boosting classifier (GBC) analysis of instrument-provided, feature-based optical coherence tomography angiography (OCTA) vessel density measurements and OCT retinal nerve fiber layer (RNFL) thickness measurements for classifying healthy and glaucomatous eyes. Comparison of diagnostic approaches. A total of 130 eyes of 80 healthy individuals and 275 eyes of 185 glaucoma patients with optic nerve head (ONH) OCTA and OCT imaging were included. Classification performance of a VGG16 CNN trained and tested on entire en face 4.5 × 4.5-mm radial peripapillary capillary OCTA ONH images was compared to the performance of separate GBC models trained and tested on standard OCTA and OCT measurements. Five-fold cross-validation was used to test predictions for CNNs and GBCs. Areas under the precision recall curves (AUPRC) were calculated to control for training/test set size imbalance and were compared. Adjusted AUPRCs for GBC models were 0.89 (95% CI = 0.82, 0.92) for whole image vessel density GBC, 0.89 (0.83, 0.92) for whole image capillary density GBC, 0.91 (0.88, 0.93) for combined whole image vessel and whole image capillary density GBC, and 0.93 (0.91, 095) for RNFL thickness GBC. The adjusted AUPRC using CNN analysis of en face vessel density images was 0.97 (0.95, 0.99) resulting in significantly improved classification compared to GBC OCTA-based results and GBC OCT-based results (P ≤ 0.01 for all comparisons). Deep learning en face image analysis improves on feature-based GBC models for classifying healthy and glaucoma eyes.

Identifiants

pubmed: 34780803
pii: S0002-9394(21)00587-0
doi: 10.1016/j.ajo.2021.11.008
pmc: PMC10042115
mid: NIHMS1875660
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

298-308

Subventions

Organisme : NEI NIH HHS
ID : R01 EY029058
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY022589
Pays : United States
Organisme : NEI NIH HHS
ID : R21 EY027945
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY027510
Pays : United States
Organisme : NEI NIH HHS
ID : K12 EY024225
Pays : United States

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Références

Am J Ophthalmol. 2019 May;201:9-18
pubmed: 30689990
Sci Rep. 2018 Nov 12;8(1):16685
pubmed: 30420630
PLoS One. 2017 Mar 13;12(3):e0173930
pubmed: 28288185
Am J Ophthalmol. 2020 Aug;216:201-206
pubmed: 31982407
Am J Ophthalmol. 1996 May;121(5):511-21
pubmed: 8610794
Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3144-51
pubmed: 15326133
PLoS One. 2019 Nov 7;14(11):e0223965
pubmed: 31697697
Ophthalmology. 2019 Apr;126(4):513-521
pubmed: 30578810
J Clin Med. 2019 Jun 18;8(6):
pubmed: 31216768
JAMA Ophthalmol. 2020 Feb 1;138(2):119-126
pubmed: 31804666
JAMA Ophthalmol. 2015 Sep;133(9):1045-52
pubmed: 26203793
Graefes Arch Clin Exp Ophthalmol. 2015 Sep;253(9):1557-64
pubmed: 26255817
IEEE Trans Biomed Eng. 2002 Sep;49(9):963-74
pubmed: 12214886
Ophthalmol Glaucoma. 2019 Mar - Apr;2(2):111-119
pubmed: 32672604
Invest Ophthalmol Vis Sci. 2002 Nov;43(11):3444-54
pubmed: 12407155
Opt Express. 2012 Feb 13;20(4):4710-25
pubmed: 22418228
Sci Rep. 2021 Jan 26;11(1):2214
pubmed: 33500462
Invest Ophthalmol Vis Sci. 2000 Jun;41(7):1730-42
pubmed: 10845593
Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug;2016:1328-1331
pubmed: 28268570
Eye (Lond). 1994;8 ( Pt 3):321-3
pubmed: 7958038
Ophthalmol Glaucoma. 2019 Jul - Aug;2(4):224-231
pubmed: 32672542
Comput Biol Med. 2019 Dec;115:103483
pubmed: 31698235
Ophthalmology. 2018 Nov;125(11):1720-1728
pubmed: 29907322
Invest Ophthalmol Vis Sci. 1994 Aug;35(9):3362-73
pubmed: 8056511
Ophthalmology. 2021 Oct;128(10):1426-1437
pubmed: 33819524
Am J Ophthalmol. 2016 Nov;171:75-83
pubmed: 27590118
Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):2748-2756
pubmed: 29860461
J Glaucoma. 2003 Aug;12(4):340-6
pubmed: 12897579
Am J Ophthalmol. 2020 Mar;211:123-131
pubmed: 31730838
Annu Rev Biomed Eng. 2017 Jun 21;19:221-248
pubmed: 28301734
Transl Vis Sci Technol. 2020 Apr 13;9(2):20
pubmed: 32818081
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):690-697
pubmed: 28134965
Ophthalmology. 2020 Aug;127(8):1043-1052
pubmed: 32085875
Invest Ophthalmol Vis Sci. 2002 Jan;43(1):162-9
pubmed: 11773027
Ophthalmol Glaucoma. 2018 Jul - Aug;1(1):15-22
pubmed: 32672627
Transl Vis Sci Technol. 2020 Apr 28;9(2):27
pubmed: 32818088
Biometrika. 2009 Jun;96(2):371-382
pubmed: 22822245
PLoS One. 2016 Aug 18;11(8):e0161631
pubmed: 27537500
Graefes Arch Clin Exp Ophthalmol. 2009 Nov;247(11):1517-30
pubmed: 19579030
Jpn J Ophthalmol. 2019 May;63(3):276-283
pubmed: 30798379
J Glaucoma. 2017 Oct;26(10):851-859
pubmed: 28858159
Am J Ophthalmol. 2019 Feb;198:136-145
pubmed: 30316669
Br J Ophthalmol. 2018 Mar;102(3):352-357
pubmed: 28739645
Open J Stat. 2016 Feb;6(1):14-24
pubmed: 27034909
NPJ Digit Med. 2018 Aug 28;1:39
pubmed: 31304320
Mil Med. 1994 Aug;159(8):553-7
pubmed: 7824147
Ophthalmology. 2020 Mar;127(3):346-356
pubmed: 31718841
Ophthalmic Res. 2018;60(3):139-151
pubmed: 29794471
Ophthalmology. 2019 Dec;126(12):1627-1639
pubmed: 31561879
Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4147-52
pubmed: 16249492
Am J Ophthalmol. 2020 Sep;217:131-139
pubmed: 32222368
Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1322-9
pubmed: 15790898
Arch Ophthalmol. 2009 Sep;127(9):1136-45
pubmed: 19752422
PLoS One. 2019 Jul 1;14(7):e0219126
pubmed: 31260494
PLoS One. 2018 Nov 27;13(11):e0207982
pubmed: 30481205
Sci Rep. 2018 Oct 2;8(1):14665
pubmed: 30279554
J Glaucoma. 1999 Feb;8(1):77-80
pubmed: 10084278
ScientificWorldJournal. 2013 Oct 27;2013:704504
pubmed: 24288502
Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3637-3645
pubmed: 28728171
Artif Intell Med. 2003 Jan;27(1):65-79
pubmed: 12473392
PLoS One. 2015 Mar 04;10(3):e0118432
pubmed: 25738806
J Glaucoma. 2007 Jan;16(1):20-8
pubmed: 17224745
Br J Ophthalmol. 2017 Sep;101(9):1261-1268
pubmed: 28148529
Sci Rep. 2021 Jan 13;11(1):1031
pubmed: 33441825

Auteurs

Christopher Bowd (C)

From the Hamilton Glaucoma Center, Shiley Eye Institute, and The Viterbi Family Department of Ophthalmology, University of California, San Diego, La Jolla, California, USA. Electronic address: cbowd@health.ucsd.edu.

Akram Belghith (A)

From the Hamilton Glaucoma Center, Shiley Eye Institute, and The Viterbi Family Department of Ophthalmology, University of California, San Diego, La Jolla, California, USA.

Linda M Zangwill (LM)

From the Hamilton Glaucoma Center, Shiley Eye Institute, and The Viterbi Family Department of Ophthalmology, University of California, San Diego, La Jolla, California, USA.

Mark Christopher (M)

From the Hamilton Glaucoma Center, Shiley Eye Institute, and The Viterbi Family Department of Ophthalmology, University of California, San Diego, La Jolla, California, USA.

Michael H Goldbaum (MH)

From the Hamilton Glaucoma Center, Shiley Eye Institute, and The Viterbi Family Department of Ophthalmology, University of California, San Diego, La Jolla, California, USA.

Rui Fan (R)

From the Hamilton Glaucoma Center, Shiley Eye Institute, and The Viterbi Family Department of Ophthalmology, University of California, San Diego, La Jolla, California, USA.

Jasmin Rezapour (J)

From the Hamilton Glaucoma Center, Shiley Eye Institute, and The Viterbi Family Department of Ophthalmology, University of California, San Diego, La Jolla, California, USA.

Sasan Moghimi (S)

From the Hamilton Glaucoma Center, Shiley Eye Institute, and The Viterbi Family Department of Ophthalmology, University of California, San Diego, La Jolla, California, USA.

Alireza Kamalipour (A)

From the Hamilton Glaucoma Center, Shiley Eye Institute, and The Viterbi Family Department of Ophthalmology, University of California, San Diego, La Jolla, California, USA.

Huiyuan Hou (H)

From the Hamilton Glaucoma Center, Shiley Eye Institute, and The Viterbi Family Department of Ophthalmology, University of California, San Diego, La Jolla, California, USA.

Robert N Weinreb (RN)

From the Hamilton Glaucoma Center, Shiley Eye Institute, and The Viterbi Family Department of Ophthalmology, University of California, San Diego, La Jolla, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH